Teprotumumab Effect on Proptosis, Diplopia and Quality of Life in Active Thyroid Eye Disease (TED) (Video)

Update Item Information
Identifier 20200309_nanos_sciplatform1_04
Title Teprotumumab Effect on Proptosis, Diplopia and Quality of Life in Active Thyroid Eye Disease (TED) (Video)
Creator Jade Schiffman; Rosa Tang; George Kahaly; Terry Smith; Saba Sile; Elizabeth Thompson; Thomas Vescio; Jeffrey Sherman; Raymond Douglas
Affiliation (JS) (RT) Eye Wellness Center, Neuro-Eye Clinical Trials, Inc, Houston, Texas; (GK) Johannes Gutenberg University Medical Center, Mainz, Germany; (TS) University of Michigan Kellogg Eye Center, Ann Arbor, Michigan; (SS) (ET) (TV) (JS) Horizon Therapeutics plc, Lake Forest, Illinois; (RD) Cedars Sinai Medical Center, Los Angeles, California
Subject Graves (Systemic Disease), Neuro-ophth & Systemic Disease (eg. MS, MG, Thyroid), Optic Neuropathy, Adult Strabismus with a Focus on Diplopia, Orbit/Ocular Pathology
Description Active thyroid eye disease (TED), a progressive, autoimmune condition, produces retro-orbital inflammation/tissue expansion. Patients present with ocular pain, redness, and swelling. Retro-orbital fat/muscle expansion produces subsequent proptosis, diplopia, and strabismus. These manifestations can persist after inflammation is no longer evident. A phase 3 placebo-controlled trial recently confirmed that teprotumumab, an IGF-1R inhibitory antibody, significantly reduced TED-associated proptosis and improved other outcomes.[1] Key TED outcomes (proptosis [mm], subjective Bahn/Gorman diplopia grade, and GO-QOL) from the teprotumumab phase 2 and 3 trials are reported here.[1,2]
Date 2020-03
Language eng
Format video/mp4
Type Image/MovingImage
Source 2020 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2020: Scientific Platform Session I
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6kt21kv
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 1541919
Reference URL https://collections.lib.utah.edu/ark:/87278/s6kt21kv
Back to Search Results